Statistics

Total Visits

Views
Bevacizumab intravitreo como tratamiento de las telangiectasias yuxtafoveales idiopaticas tipo i59

Select a period of time:

Number of views in the range

Views
Bevacizumab intravitreo como tratamiento de las telangiectasias yuxtafoveales idiopaticas tipo i27

Views

Views
October 20259
November 20251
December 20253
January 20267
February 20262
March 20265
April 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States7
Finland5
United Kingdom3
Brazil3
Austria2
Argentina1
Australia1
Canada1
China1
Germany1
 

Top cities views

Views
Helsinki5
Charlotte1
Coral Springs1
Dakar1
Durrington1
Hinesville1
Los Angeles1
Maringá1
Munich1
Phoenix1